The new state of the art: Cas9 for gene activation and repression

Molecular and Cellular Biology

Volumn 35, Issue 22, 2015, Pages 3800-3809

  La Russa, Marie F ^a,b   Qib, Lei S ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Stanford University   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; BASE PAIRING; CELL MIGRATION; CRISPR CAS SYSTEM; CRISPR CAS9; DROSOPHILA MELANOGASTER; GENE ACTIVATION; GENE CONTROL; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; MAMMAL CELL; NONHUMAN; OPEN READING FRAME; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RNA INTERFERENCE; SACCHAROMYCES CEREVISIAE; SHORT SURVEY; TRANSCRIPTION INITIATION; UPREGULATION; ANIMAL; BACTERIUM; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; GENETICS; PROCEDURES;

ANIMALS; BACTERIA; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-CAS SYSTEMS; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; HUMANS;

EID: 84944632276     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00512-15     Document Type: Short Survey

References (82)

1. Horvath P, Barrangou R. 2010. CRISPR/Cas, the immune system of bacteria and archaea. Science 327:167-170.
2. Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, Eckert MR, Vogel J, Charpentier E. 2011. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471:602-607.
3. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816-821.
4. Gasiunas G, Barrangou R, Horvath P, Siksnys V. 2012. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci U S A 109:E2579-E2586. http://dx.doi.org/10.1073/pnas.1208507109.
5. Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, Cradick TJ, Marraffini LA, Bao G, Zhang F. 2013. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31:827-832.
6. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339:819-823.
7. Cho SW, Kim S, Kim JM, Kim J-S. 2013. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol 31:230-232.
8. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. 2013. RNA-guided human genome engineering via Cas9. Science 339:823-826.
9. Yang H, Wang H, Shivalila CS, Cheng AW, Shi L, Jaenisch R. 2013. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 154:1370-1379.
10. Hou Z, Zhang Y, Propson NE, Howden SE, Chu L-F, Sontheimer EJ, Thomson JA. 2013. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci U S A 110:15644-15649. http://dx.doi.org/10.1073/pnas.1313587110.
11. Jiang W, Cox D, Zhang F, Bikard D, Marraffini LA. 2013. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol 31:233-239.
12. DiCarlo JE, Norville JE, Mali P, Rios X, Aach J, Church GM. 2013. Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res 41:4336-4343. http://dx.doi.org/10.1093/nar/gkt135.
13. Bortesi L, Fischer R. 2015. The CRISPR/Cas9 system for plant genome editing and beyond. Biotechnol Adv 33:41-52. http://dx.doi.org/10.1016/j.biotechadv.2014.12.006.
14. Gratz SJ, Cummings AM, Nguyen JN, Hamm DC, Donohue LK, Harrison MM, Wildonger J, O'Connor-Giles KM. 2013. Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics 194:1029-1035. http://dx.doi.org/10.1534/genetics.113.152710.
15. Mali P, Esvelt KM, Church GM. 2013. Cas9 as a versatile tool for engineering biology. Nat Methods 10:957-963. http://dx.doi.org/10.1038/nmeth.2649.
16. Hsu PD, Lander ES, Zhang F. 2014. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157:1262-1278. http://dx.doi.org/10.1016/j.cell.2014.05.010.
17. Cox DBT, Platt RJ, Zhang F. 2015. Therapeutic genome editing: prospects and challenges. Nat Med 21:121-131. http://dx.doi.org/10.1038/nm.3793.
18. Doudna JA, Charpentier E. 2014. The new frontier of genome engineering with CRISPR-Cas9. Science 346:1258096-1258096. http://dx.doi.org/10.1126/science.1258096.
19. Sapranauskas R, Gasiunas G, Fremaux C, Barrangou R, Horvath P, Siksnys V. 2011. The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Res 39:9275-9282. http://dx.doi.org/10.1093/nar/gkr606.
20. Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, Lim WA. 2013. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152:1173-1183. http://dx.doi.org/10.1016/j.cell.2013.02.022.
21. Konermann S, Brigham MD, Trevino AE, Hsu PD, Heidenreich M, Cong L, Platt RJ, Scott DA, Church GM, Zhang F. 2013. Optical control of mammalian endogenous transcription and epigenetic states. Nature 500:472-476.
22. Mali P, Aach J, Stranges PB, Esvelt KM, Moosburner M, Kosuri S, Yang L, Church GM. 2013. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol 31:833-838. http://dx.doi.org/10.1038/nbt.2675.
23. Bikard D, Jiang W, Samai P, Hochschild A, Zhang F, Marraffini LA. 2013. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res 41:7429-7437. http://dx.doi.org/10.1093/nar/gkt520.
24. Gilbert LA, Larson MH, Morsut L, Liu Z, Brar GA, Torres SE, Stern-Ginossar N, Brandman O, Whitehead EH, Doudna JA, Lim WA, Weissman JS, Qi LS. 2013. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154:442-451. http://dx.doi.org/10.1016/j.cell.2013.06.044.
25. Maeder ML, Linder SJ, Cascio VM, Fu Y, Ho QH, Joung JK. 2013. CRISPR RNA-guided activation of endogenous human genes. Nat Methods 10:977-981. http://dx.doi.org/10.1038/nmeth.2598.
26. Perez-Pinera P, Kocak DD, Vockley CM, Adler AF, Kabadi AM, Polstein LR, Thakore PI, Glass KA, Ousterout DG, Leong KW, Guilak F, Crawford GE, Reddy TE, Gersbach CA. 2013. RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods 10:973-976. http://dx.doi.org/10.1038/nmeth.2600.
27. Cheng AW, Wang H, Yang H, Shi L, Katz Y, Theunissen TW, Rangarajan S, Shivalila CS, Dadon DB, Jaenisch R. 2013. Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res 23:1163-1171. http://dx.doi.org/10.1038/cr.2013.122.
28. Tanenbaum ME, Gilbert LA, Qi LS, Weissman JS, Vale RD. 2014. A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell 159:635-646. http://dx.doi.org/10.1016/j.cell.2014.09.039.
29. Gilbert LA, Horlbeck MA, Adamson B, Villalta JE, Chen Y, Whitehead EH, Guimaraes C, Panning B, Ploegh HL, Bassik MC, Qi LS, Kampmann M, Weissman JS. 2014. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159:647-661. http://dx.doi.org/10.1016/j.cell.2014.09.029.
30. Zalatan JG, Lee ME, Almeida R, Gilbert LA, Whitehead EH, LaRussa M, Tsai JC, Weissman JS, Dueber JE, Qi LS, Lim WA. 2015. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell 160:339-350. http://dx.doi.org/10.1016/j.cell.2014.11.052.
31. Chavez A, Scheiman J, Vora S, Pruitt BW, Tuttle M, Iyer EPR, Lin S, Kiani S, Guzman CD, Wiegand DJ, Ter-Ovanesyan D, Braff JL, Davidsohn N, Housden BE, Perrimon N, Weiss R, Aach J, Collins JJ, Church GM. 2 March 2015, posting date. Highly efficient Cas9-mediated transcriptional programming. Nat Methods http://dx.doi.org/10.1038/nmeth.3312.
32. Konermann S, Brigham MD, Trevino AE, Joung J, Abudayyeh OO, Barcena C, Hsu PD, Habib N, Gootenberg JS, Nishimasu H, Nureki O, Zhang F. 2015. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517:583-588.
33. Hilton IB, D'Ippolito AM, Vockley CM, Thakore PI, Crawford GE, Reddy TE, Gersbach CA. 6 April 2015, posting date. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol http://dx.doi.org/10.1038/nbt.3199.
34. Liu Y, Zeng Y, Liu L, Zhuang C, Fu X, Huang W, Cai Z. 2014. Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells. Nat Commun 5:5393. http://dx.doi.org/10.1038/ncomms6393.
35. Wang T, Wei JJ, Sabatini DM, Lander ES. 2014. Genetic screens in human cells using the CRISPR/Cas9 system. Science 343:80-84.
36. Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, Heckl D, Ebert BL, Root DE, Doench JG, Zhang F. 2014. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343:84-87.
37. Zhou Y, Zhu S, Cai C, Yuan P, Li C, Huang Y, Wei W. 9 April 2014, posting date. High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells. Nature http://dx.doi.org/10.1038/nature13166.
38. Perez-Pinera P, Ousterout DG, Brunger JM, Farin AM, Glass KA, Guilak F, Crawford GE, Hartemink AJ, Gersbach CA. 2013. Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nat Methods 10:239-242. http://dx.doi.org/10.1038/nmeth.2361.
39. Polstein L, Perez-Pinera P, Kocak D, Vockley C, Bledsoe P, Song L, Safi A, Crawford G, Reddy T, Gersbach C. 29 May 2015, posting date. Genome-wide specificity of DNA-binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activators. Genome Res http://dx.doi.org/10.1101/gr.179044.114.
40. Wu X, Scott DA, Kriz AJ, Chiu AC, Hsu PD, Dadon DB, Cheng AW, Trevino AE, Konermann S, Chen S, Jaenisch R, Zhang F, Sharp PA. 20 April 2014, posting date. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat Biotechnol http://dx.doi.org/10.1038/nbt.2889.
41. Kuscu C, Arslan S, Singh R, Thorpe J, Adli M. 18 May 2014, posting date. Genome-wide analysis reveals characteristics of off-target sites bound by the cas9 endonuclease. Nat Biotechnol http://dx.doi.org/10.1038/nbt.2916.
42. Sternberg SH, Redding S, Jinek M, Greene EC, Doudna JA. 29 January 2014, posting date. DNA interrogation by the CRISPRRNA-guided endonuclease Cas9. Nature http://dx.doi.org/10.1038/nature13011.
43. Jiang F, Zhou K, Ma L, Gressel S, Doudna JA. 2015. A Cas9-guide RNA complex preorganized for target DNA recognition. Science 348:1477-1481. http://dx.doi.org/10.1126/science.aab1452.
44. Larson MH, Gilbert LA, Wang X, Lim WA, Weissman JS, Qi LS. 2013. CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat Protoc 8:2180-2196. http://dx.doi.org/10.1038/nprot.2013.132.
45. Prelich G. 2012. Gene overexpression: uses, mechanisms, and interpretation. Genetics 190:841-854. http://dx.doi.org/10.1534/genetics.111.136911.
46. Reboul J, Vaglio P, Rual J-F, Lamesch P, Martinez M, Armstrong CM, Li S, Jacotot L, Bertin N, Janky R, Moore T, Hudson JR, Hartley JL, Brasch MA, Vandenhaute J, Boulton S, Endress GA, Jenna S, Chevet E, Papasotiropoulos V, Tolias PP, Ptacek J, Snyder M, Huang R, Chance MR, Lee H, Doucette-Stamm L, Hill DE, Vidal M. 2003. C. elegans ORFeome version 1.1: experimental verification of the genome annotation and resource for proteome-scale protein expression. Nat Genet 34: 35-41. http://dx.doi.org/10.1038/ng1140.
47. Rual J-F, Hirozane-Kishikawa T, Hao T, Bertin N, Li S, Dricot A, Li N, Rosenberg J, Lamesch P, Vidalain P-O, Clingingsmith TR, Hartley JL, Esposito D, Cheo D, Moore T, Simmons B, Sequerra R, Bosak S, Doucette-Stamm L, Le Peuch C, Vandenhaute J, Cusick ME, Albala JS, Hill DE, Vidal M. 2004. Human ORFeome version 1.1: a platform for reverse proteomics. Genome Res 14:2128-2135. http://dx.doi.org/10.1101/gr.2973604.
48. Lamesch P, Li N, Milstein S, Fan C, Hao T, Szabo G, Hu Z, Venkatesan K, Bethel G, Martin P, Rogers J, Lawlor S, McLaren S, Dricot A, Borick H, Cusick ME, Vandenhaute J, Dunham I, Hill DE, Vidal M. 2007. hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes. Genomics 89:307-315. http://dx.doi.org/10.1016/j.ygeno.2006.11.012.
49. Yang X, Boehm JS, Yang X, Salehi-Ashtiani K, Hao T, Shen Y, Lubonja R, Thomas SR, Alkan O, Bhimdi T, Green TM, Johannessen CM, Silver SJ, Nguyen C, Murray RR, Hieronymus H, Balcha D, Fan C, Lin C, Ghamsari L, Vidal M, Hahn WC, Hill DE, Root DE. 2011. A public genome-scale lentiviral expression library of human ORFs. Nat Methods 8:659-661. http://dx.doi.org/10.1038/nmeth.1638.
50. Zhang F, Cong L, Lodato S, Kosuri S, Church GM, Arlotta P. 2011. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol 29:149-153. http://dx.doi.org/10.1038/nbt.1775.
51. Choo Y, Isalan M. 2000. Advances in zinc finger engineering. Curr Opin Struct Biol 10:411-416. http://dx.doi.org/10.1016/S0959-440X(00)00107-X.
52. Deng D, Yin P, Yan C, Pan X, Gong X, Qi S, Xie T, Mahfouz M, Zhu J-K, Yan N, Shi Y. 2012. Recognition of methylated DNA by TAL effectors. Cell Res 22:1502-1504. http://dx.doi.org/10.1038/cr.2012.127.
53. Valton J, Dupuy A, Daboussi F, Thomas S, Maréchal A, Macmaster R, Melliand K, Juillerat A, Duchateau P. 2012. Overcoming transcription activator-like effector (TALE) DNA binding domain sensitivity to cytosine methylation. J Biol Chem 287:38427-38432. http://dx.doi.org/10.1074/jbc.C112.408864.
54. Yang J, Yuan P, Wen D, Sheng Y, Zhu S, Yu Y, Gao X, Wei W. 2013. ULtiMATE system for rapid assembly of customized TAL effectors. PLoS One 8:e75649. http://dx.doi.org/10.1371/journal.pone.0075649.
55. Cermak T, Doyle EL, Christian M, Wang L, Zhang Y, Schmidt C, Baller JA, Somia NV, Bogdanove AJ, Voytas DF. 2011. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 39:e82. http://dx.doi.org/10.1093/nar/gkr218.
56. Sera T. 2009. Zinc-finger-based artificial transcription factors and their applications. Adv Drug Deliv Rev 61:513-526. http://dx.doi.org/10.1016/j.addr.2009.03.012.
57. Conrad C, Erfle H, Warnat P, Daigle N, Lörch T, Ellenberg J, Pepperkok R, Eils R. 2004. Automatic identification of subcellular phenotypes on human cell arrays. Genome Res 14:1130-1136. http://dx.doi.org/10.1101/gr.2383804.
58. Beerli RR, Segal DJ, Dreier B, Barbas CF. 1998. Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc Natl Acad Sci U S A 95:14628-14633. http://dx.doi.org/10.1073/pnas.95.25.14628.
59. Beerli RR, Dreier B, Barbas CF. 2000. Positive and negative regulation of endogenous genes by designed transcription factors. Proc Natl Acad Sci U S A 97:1495-1500. http://dx.doi.org/10.1073/pnas.040552697.
60. Blancafort P. 2004. Designing transcription factor architectures for drug discovery. Mol Pharmacol 66:1361-1371. http://dx.doi.org/10.1124/mol.104.002758.
61. Maeder ML, Linder SJ, Reyon D, Angstman JF, Fu Y, Sander JD, Joung JK. 2013. Robust, synergistic regulation of human gene expression using TALE activators. Nat Methods 10:243-245. http://dx.doi.org/10.1038/nmeth.2366.
62. Yang J, Zhang Y, Yuan P, Zhou Y, Cai C, Ren Q, Wen D, Chu C, Qi H, Wei W. 2014. Complete decoding of TAL effectors for DNA recognition. Cell Res 24:628-631. http://dx.doi.org/10.1038/cr.2014.19.
63. Bultmann S, Morbitzer R, Schmidt CS, Thanisch K, Spada F, Elsaesser J, Lahaye T, Leonhardt H. 2012. Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers. Nucleic Acids Res 40:5368-5377. http://dx.doi.org/10.1093/nar/gks199.
64. Zhao Y, Dai Z, Liang Y, Yin M, Ma K, He M, Ouyang H, Teng C-B. 3 February 2014, posting date. Sequence-specific inhibition of microRNA via CRISPR/CRISPRi system. Sci Rep http://dx.doi.org/10.1038/srep03943.
65. Mello CC, Conte D. 2004. Revealing the world of RNA interference. Nature 431:338-342. http://dx.doi.org/10.1038/nature02872.
66. Khan AA, Betel D, Miller ML, Sander C, Leslie CS, Marks DS. 25 November 2009, posting date. Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat Biotechnol http://dx.doi.org/10.1038/nbt.1543.
67. Sigoillot FD, Lyman S, Huckins JF, Adamson B, Chung E, Quattrochi B, King RW. 2012. A bioinformatics method identifies prominent offtargeted transcripts in RNAi screens. Nat Methods 9:363-366. http://dx.doi.org/10.1038/nmeth.1898.
68. Birmingham A, Anderson EM, Reynolds A, Ilsley-Tyree D, Leake D, Fedorov Y, Baskerville S, Maksimova E, Robinson K, Karpilow J, Marshall WS, Khvorova A. 2006. 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods 3:199-204. http://dx.doi.org/10.1038/nmeth854.
69. Kampmann M, Horlbeck MA, Chen Y, Tsai JC, Bassik MC, Gilbert LA, Villalta JE, Kwon SC, Chang H, Kim VN, Weissman JS. 2015. Nextgeneration libraries for robust RNA interference-based genome-wide screens. Proc Natl Acad Sci U S A 112:E3384-E3391. http://dx.doi.org/10.1073/pnas.1508821112.
70. Ha M, Kim VN. 2014. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15:509-524. http://dx.doi.org/10.1038/nrm3838.
71. Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233. http://dx.doi.org/10.1016/j.cell.2009.01.002.
72. Meister G, Landthaler M, Dorsett Y, Tuschl T. 2004. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10: 544-550. http://dx.doi.org/10.1261/rna.5235104.
73. Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. 2005. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438:685-689. http://dx.doi.org/10.1038/nature04303.
74. Ebert MS, Neilson JR, Sharp PA. 2007. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4:721-726. http://dx.doi.org/10.1038/nmeth1079.
75. Carthew RW, Sontheimer EJ. 2009. Origins and mechanisms of miRNAs and siRNAs. Cell 136:642-655. http://dx.doi.org/10.1016/j.cell.2009.01.035.
76. Hutvagner G, Simard MJ. 2008. Argonaute proteins: key players in RNA silencing. Nat Rev Mol Cell Biol 9:22-32. http://dx.doi.org/10.1038/nrm2321.
77. Bhinder B, Djaballah H. 2013. Systematic analysis of RNAi reports identifies dismal commonality at gene-level&reveals an unprecedented enrichment in pooled shRNA screens. Comb Chem High Throughput Screen 16:665-681. http://dx.doi.org/10.2174/13862073113169990045.
78. Franceschini A, Meier R, Casanova A, Kreibich S, Daga N, Andritschke D, Dilling S, Rämö P, Emmenlauer M, Kaufmann A, Conde-Álvarez R, Low SH, Pelkmans L, Helenius A, Hardt WD, Dehio C, von Mering C. 2014. Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screens. Proc Natl Acad Sci U S A 111:4548-4553. http://dx.doi.org/10.1073/pnas.1402353111.
79. Buehler E, Chen Y-C, Martin S. 2012. C911: a bench-level control for sequence specific siRNA off-target effects. PLoS One 7:e51942. http://dx.doi.org/10.1371/journal.pone.0051942.
80. Bassik MC, Kampmann M, Lebbink RJ, Wang S, Hein MY, Poser I, Weibezahn J, Horlbeck MA, Chen S, Mann M, Hyman AA, Leproust EM, McManus MT, Weissman JS. 2013. A systematic mammalian genetic interaction map reveals pathways underlying ricin susceptibility. Cell 152:909-922. http://dx.doi.org/10.1016/j.cell.2013.01.030.
81. Doench JG, Hartenian E, Graham DB, Tothova Z, Hegde M, Smith I, Sullender M, Ebert BL, Xavier RJ, Root DE. 2014. Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat Biotechnol 32:1262-1267. http://dx.doi.org/10.1038/nbt.3026.
82. Fedorov Y, Anderson EM, Birmingham A, Reynolds A, Karpilow J, Robinson K, Leake D, Marshall WS, Khvorova A. 2006. Off-target effects by siRNA can induce toxic phenotype. RNA 12:1188-1196. http://dx.doi.org/10.1261/rna.28106.